Education
About Us
Working with TipRanks
Follow Us
Alaleh Nouri Insider Profile
11 Followers
Alaleh Nouri, SVP, General Counsel & at Accuray, holds 61.79K shares in PROCEPT BioRobotics (Ticker: PRCT), holds 195.92K shares in Accuray (Ticker: ARAY). Most recently, Alaleh Nouri Sold ― shares of PROCEPT BioRobotics on Mar 10, 2025 for an estimated value of 223.23K.
Profitable Transactions
5 out of 10 Profitable Transactions
Average Return
-1.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alaleh Nouri holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alaleh Nouri
Alaleh Nouri's Trading History
Accuray
Jul 03, 2018
SVP, General Counsel &
Informative Sell
34.84K
$364.42K
PROCEPT BioRobotics
Mar 10, 2025
EVP, CLO, CORP. SEC
Informative Sell
223.23K
$3.67M
List of latest transactions for each holding click on a transaction to see Alaleh Nouri's performance on stock
You May Also Like
Alaleh Nouri insider profile FAQ
What is the percentage of profitable transactions made by Alaleh Nouri?
The percentage of profitable transactions made by Alaleh Nouri is 50%.
What is the average return per transaction made by Alaleh Nouri?
The average return per transaction made by Alaleh Nouri is -1.40%.
What stocks does Alaleh Nouri hold?
Alaleh Nouri holds: ARAY, PRCT stocks.
What was Alaleh Nouri’s latest transaction?
Alaleh Nouri latest transaction was an Informative Sell of $223.23K.
What was Alaleh Nouri's most profitable transaction?
Alaleh Nouri’s most profitable transaction was an Informative Sell of ARAY stock on February 3, 2015. The return on the trade was 25.80%.
What is Alaleh Nouri's role in Accuray?
Alaleh Nouri's role in Accuray is SVP, General Counsel &.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.